Menu

Cervical Cancer Screening Update: Pap, HPV Co-Testing, and Self-Swabs
Dr. Michael Zimmer

Dr. Michael A. Zimmer

Cervical Cancer Screening Update: Pap, HPV Co-Testing, and Self-Swabs

Medically reviewed by Michael A. Zimmer, MD, MACPBoard-Certified Internal Medicine, Medical Director
Post Summary

Cervical cancer screening has changed substantially. Primary HPV testing, co-testing, and — as of 2024 — self-collected swabs are all options now. Here is the current USPSTF and ACS guidance and how to talk with your doctor about which schedule fits you.

Cervical Cancer Screening in 2026: Pap, HPV, and the New Self-Swab Option

Cervical cancer is one of the most preventable cancers we know of, largely because screening works. Over the past two decades, deaths from cervical cancer have fallen sharply in the United States, and nearly every case we still see occurs in someone who was not screened on schedule, or who fell behind. If you are not sure when your last Pap was, you are not alone, and this article will help you get back on track.

At Zimmer Medical Group in St. Petersburg, Dr. Michael A. Zimmer and team coordinate cervical cancer screening as part of your broader preventive care plan. Here is what current guidelines actually say, what the new options look like, and when you should book a visit.

What the Guidelines Recommend

The U.S. Preventive Services Task Force recommendations, along with guidance from the American College of Obstetricians and Gynecologists and the CDC, converge on a clear framework.

  • Ages 21 to 29: Cytology (Pap smear) alone every 3 years.
  • Ages 30 to 65: One of three strategies — Pap every 3 years, primary HPV testing every 5 years, or co-testing (Pap plus HPV) every 5 years.
  • Under 21: No screening, even if sexually active. Early abnormalities in this age group almost always resolve on their own.
  • Over 65: Screening can usually stop if you have a documented history of adequate prior normal screening and no history of high-grade lesions.

You may notice guidelines are shifting toward HPV primary testing. That is because HPV testing is more sensitive than cytology for detecting cervical precancer, and longer intervals are possible because a negative HPV test is highly reassuring.

Self-Swab HPV: The Newest Option

In 2024, the FDA approved self-collected HPV samples for in-clinic use. Instead of a speculum exam, you collect a vaginal swab yourself in a private exam room, and we send it to the lab. For women who have avoided Pap smears because of discomfort, anxiety, or prior trauma, this has been a meaningful step forward. Home-based self-collection programs are in late-stage development and likely to expand further.

Self-swab is not yet the right answer for everyone — if a woman has symptoms, a prior abnormal result, or needs a bimanual exam for other reasons, a traditional visit is still appropriate. But as an access tool, it is changing the conversation.

If Your Result Is Abnormal

Abnormal results do not mean cancer. The most common findings are ASC-US (atypical squamous cells of undetermined significance), LSIL (low-grade), and HSIL (high-grade). Low-grade changes often resolve on their own, while high-grade changes or persistent HPV typically lead to colposcopy — a magnified exam of the cervix with targeted biopsies. We walk you through every step, and most women never need more than observation.

Vaccination Does Not Replace Screening

The HPV vaccine dramatically reduces the risk of cervical cancer, especially when given before any HPV exposure. But even vaccinated women still need screening under current U.S. guidelines. Ongoing trials are evaluating whether vaccinated women can screen less often, and guidance may evolve — but for now, do not skip your Pap or HPV test because you were vaccinated.

Special Populations

  • HIV-positive or immunocompromised: Start screening earlier and more frequently.
  • After hysterectomy: If your cervix was removed for a benign reason (like fibroids), you generally do not need further cervical screening. If it was removed for a high-grade lesion or cancer, continued vaginal cuff screening is recommended.
  • DES exposure in utero: Continue screening regardless of age.
  • History of CIN 2 or higher: Extended surveillance for at least 25 years.

If You Fell Behind During the Pandemic

Millions of women missed Pap and HPV tests between 2020 and 2022. If you are one of them, please do not let embarrassment delay you further. A quick visit now closes the gap and gives you the same protection you had before.

Cervical screening fits naturally into your overall preventive plan — along with breast cancer screening, your annual physical, and preventive care tailored to St. Pete residents. Knowing your family medical history also helps us personalize risk.

Screening After 50, and the Questions Patients Ask

Many of the women I see for cervical screening are past menopause, and the questions at that stage are different from the ones at 30.

Making the exam comfortable after menopause

Thinning and dryness of vaginal tissue, the genitourinary syndrome of menopause, is the main reason a Pap becomes uncomfortable after 50, and it also produces more results that come back as unsatisfactory or showing mild changes that are not precancer. A short course of vaginal estrogen in the weeks before the visit makes the exam easier and the sample better; tell us if you have avoided screening for this reason. Self-collected HPV testing removes the speculum entirely and is a reasonable option for many women in this situation. The National Cancer Institute explains how the tests differ.

When it is safe to stop

Stopping at 65 depends on having been adequately screened, not on the birthday alone. In practice that means recent negative results within the last decade, with the most recent test within the past five years, and no history of a high-grade lesion. A woman who has not been screened in fifteen years is not done at 65; she needs to catch up first. Someone whose cervix was removed for a benign reason can stop, while a history of a serious precancer keeps screening going for many years afterward. MedlinePlus summarizes those stopping rules in plain language, and our cancer screenings by age article puts them beside the other tests due in the same decade.

What raises risk beyond HPV itself

Nearly all cervical cancer starts with persistent HPV infection, but what lets the infection persist matters. Smoking roughly doubles the risk, and our nicotine dependence page covers the treatments that work. Immune suppression, whether from HIV, a transplant, or long-term treatment for an autoimmune disease, shortens the screening interval. And the transition through menopause does not clear a prior HPV infection; a positive HPV test at 55 can reflect a virus acquired decades earlier. Vaccination still helps adults under 45 who were never immunized, and our HPV vaccine catch-up article explains who qualifies.

Bring This Up at Your Next Visit

If you are due — or overdue — for cervical cancer screening, we can take care of it during a regular visit. Schedule an appointment with Dr. Zimmer and we will review your history, choose the test that fits you best, and make it as comfortable as possible.

Frequently Asked Questions

Yes, until you meet the criteria to stop. Menopause does not end the risk, because a persistent HPV infection from years earlier can still progress, and the average age of cervical cancer diagnosis in the United States is in the late forties to fifties. If the exam has become uncomfortable because of vaginal dryness, a short course of vaginal estrogen beforehand or a self-collected HPV swab makes it manageable. Screening continues on the usual interval until 65 with adequate prior results.
You can stop if you have a documented history of adequate recent screening, meaning several consecutive normal results within the past decade with the most recent within the past five years, and no history of a high-grade cervical precancer or cancer. If you cannot find those records, or you have not been screened in many years, the safer path is one more round of testing before stopping. We will look at your history together and decide.
For detecting the high-risk HPV types that cause nearly all cervical cancer, a self-collected vaginal swab performs comparably to a clinician-collected HPV sample in studies. It does not include a Pap cytology reading, so a positive HPV result leads to a follow-up visit for a Pap or colposcopy. It is a strong option for women who have avoided screening because of discomfort or past trauma, and less suitable when there are symptoms or a prior abnormal result.
Yes. Women who smoke are roughly twice as likely to develop cervical cancer as those who do not, because tobacco byproducts reach cervical tissue and weaken the local immune response that normally clears HPV. Quitting lowers that risk over time and improves the odds that a current HPV infection clears on its own. It is one of the few cervical cancer risk factors you can change, and we can help with medication and support to do it.